Clin J Am Soc Nephrol

1. MARTINEZ-AMEZCUA P, Fuentes-Mercado A, Etzkorn LH, Schrack JA, et al
   Differences in Physical Activity Assessed by Accelerometry Across Hemodialysis Days and Shifts.
   Clin J Am Soc Nephrol. 2025 Oct 27. doi: 10.2215/CJN.0000000914.
   

   >> Share

   
   
2. BANSAL N, Rivara M, Sarathy H, Clark C, et al
   A Qualitative Study of Nephrologists' Perceptions of Management of Hypertension in Hemodialysis Patients.
   Clin J Am Soc Nephrol. 2025 Oct 27. doi: 10.2215/CJN.0000000885.
   

   >> Share

   
   

   
   Curr Opin Nephrol Hypertens

3. BANSAL S, Nararyan R
   Management of peritoneal dialysis in patients with obesity.
   Curr Opin Nephrol Hypertens. 2025 Oct 24. doi: 10.1097/MNH.0000000000001124.
   

   >> Share

   
   

   
   J Am Soc Nephrol

4. MAYNE KJ, Herrington WG
   "Hi"s and "Lo"s of Targeting Serum Phosphate Levels in Hemodialysis.
   J Am Soc Nephrol. 2025 Oct 30. doi: 10.1681/ASN.0000000903.
   

   >> Share

   
   

   
   J Nephrol

5. KANAKUBO Y, Inanaga R, Toida T, Aita T, et al
   Correction: Trust in physicians as a mediator of the relationship between person-centered care and medication adherence in patients undergoing hemodialysis: a cross-sectional study.
   J Nephrol. 2025 Oct 29. doi: 10.1007/s40620-025-02457.
   

   >> Share

   
   
6. ITO S, Matsumoto M, Shimono A, Teranishi H, et al
   Characteristics and clinical courses of patients with atypical haemolytic uraemic syndrome on dialysis withdrawal after eculizumab treatment: sub-analysis of post-marketing surveillance in Japan.
   J Nephrol. 2025 Oct 28. doi: 10.1007/s40620-025-02433.
   

   >> Share

   
   
7. QIAO Y, Gao S, Li S, Pei H, et al
   The association between empirical antibiotic regimens and the outcome of peritoneal dialysis-related peritonitis: a multi-center, large-scale cohort study.
   J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02437.
   

   >> Share

   
   
8. CHOQUET Q, Novel-Catin E, Laubacher M, Massat M, et al
   Contrast-induced encephalopathy after cerebral aneurysm embolization in a chronic hemodialysis patient: a case-report.
   J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02374.
   

   >> Share

   
   
9. PAGES H, Kosmadakis G, Kanouni FE, Necoara A, et al
   Evaluation of multidisciplinary care pathways on kidney function in patients with advanced chronic kidney disease: multicenter study.
   J Nephrol. 2025 Oct 27. doi: 10.1007/s40620-025-02365.
   

   >> Share

   
   
10. ELKERAIE A, Elraggal M, AbouKhatwa M, Omar ME, et al
    Safety of SGLT2 inhibitors in chronic kidney disease patients during Ramadan fasting: a prospective cohort study.
    J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02438.
    

    >> Share

    
    
11. CHUANG GT, Hsiung CN, Che TP, Oh KH, et al
    Correction: Genome-wide polygenic risk score for estimated glomerular filtration slope predicts chronic kidney disease in a Taiwanese population.
    J Nephrol. 2025 Oct 24. doi: 10.1007/s40620-025-02456.
    

    >> Share

    
    

    
    J Ren Nutr

12. BAL AZ, Turgay G, Tekinyildiz M, Sezer S, et al
    Decreased Olfactory Function is associated with Mortality in Hemodialysis Patients.
    J Ren Nutr. 2025 Oct 23:S1051-2276(25)00221-3. doi: 10.1053/j.jrn.2025.
    

    >> Share

    
    
13. HAMDAN H, Kim TY, Plantinga LC, Seligman H, et al
    Diet Quality, Food Insecurity and Chronic Kidney Disease: Insights from the U.S. National Health and Nutrition Examination Survey.
    J Ren Nutr. 2025 Oct 23:S1051-2276(25)00222-5. doi: 10.1053/j.jrn.2025.
    

    >> Share

    
    
14. MOHAMMADI MA, Behrouz V, Shahabi A, Abbas-Hashemi SA, et al
    The association between dietary inflammatory index and risk of chronic kidney disease: an updated systematic review and dose-response meta-analysis of observational studies.
    J Ren Nutr. 2025 Oct 23:S1051-2276(25)00223-7. doi: 10.1053/j.jrn.2025.
    

    >> Share

    
    

    
    N Engl J Med

15. ASSIL R, Hough A
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1753-1754.
    

    >> Share

    
    
16. SILVER S
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1754.
    

    >> Share

    
    
17. ROMAGNANI P, Soler MJ, Fervenza FC
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2025;393:1754.
    

    >> Share

    
    
18. AGARWAL R, Rossing P, Mann JFE
    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. Reply.
    N Engl J Med. 2025;393:1755.
    

    >> Share

    
    

    
    Nephrol Dial Transplant

19. HEERSPINK HJL, van Raalte DH, Bjornstad P, Bunck MC, et al
    Rationale, Design, and Baseline Characteristics of the TRANSCEND-CKD trial of Retatrutide in Patients with Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Oct 29:gfaf230. doi: 10.1093.
    

    >> Share

    
    
20. MORALES E, Jenssen TG, Bevc S, Miglinas M, et al
    Obesity as a modifiable risk factor in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Oct 30:gfaf231. doi: 10.1093.
    

    >> Share

    
    
21. VIRAMONTES-HORNER D, Stewart P, Stewart J, Taal MW, et al
    A novel system to continuously estimate intradialytic blood pressure in real time.
    Nephrol Dial Transplant. 2025;40:2074-2080.
    

    >> Share

    
    
22. HAUPENTHAL F, Doberer K, Kapps S, Klager J, et al
    Self-reported Non-adherence to Immunosuppressive Medication Detected by the BAASIS Predicts Allograft Rejections in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 28:gfaf078. doi: 10.1093.
    

    >> Share

    
    
23. SIM JJ, Chen Q, Cannizzaro N, Fernandes AW, et al
    CKD progression, kidney failure, and mortality among US patients with IgA nephropathy.
    Nephrol Dial Transplant. 2025;40:2104-2117.
    

    >> Share

    
    
24. SATISH P, Smith R, Alasadi A, Frackiewicz E, et al
    A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality.
    Nephrol Dial Transplant. 2025;40:2159-2168.
    

    >> Share

    
    

    
    Nephron

25. CETIN GUVENC R, Guvenc TS, Karakaya ES, Acik H, et al
    Abnormal Right Ventricular to Pulmonary Artery Coupling in Patients with End-Stage Kidney Disease and Normalization After Renal Transplantation: An Observational Study.
    Nephron. 2025 Oct 30:1-18. doi: 10.1159/000549077.
    

    >> Share

    
    

    
    Osteoporos Int

26. ABDALBARY M, Amin AM, Elaraby A, Hassan A, et al
    Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review.
    Osteoporos Int. 2025 Oct 31. doi: 10.1007/s00198-025-07707.
    

    >> Share

    
    

    
    PLoS One

27. DIAZ-OBREGON DZ, Goyoneche Linares G, Granda Alacote A, Murillo Carrasco AG, et al
    Variability of the lymphocyte-to-monocyte ratio in patients with chronic kidney disease on hemodialysis.
    PLoS One. 2025;20:e0333523.
    

    >> Share

    
    
28. ANOKYE R, Larkin J, Fehintola A, Eustace-Cook J, et al
    Understanding the social dimensions of kidney care pathways: A scoping review protocol.
    PLoS One. 2025;20:e0335597.
    

    >> Share

    
    
29. JIANG Y, Cui C, Nan H, Chang T, et al
    Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients.
    PLoS One. 2025;20:e0335599.
    

    >> Share

    
    

    
    Ren Fail

30. ZHANG Y, Yuan R, Li D
    Association between triglyceride-glucose index and risk of chronic kidney disease: a meta-analysis.
    Ren Fail. 2025;47:2572356.
    

    >> Share

    
    
31. YE Y, Liu S, Shao S, Gu Y, et al
    Association between sensitivity to thyroid hormone indices and chronic kidney disease in US adults from NHANES 2007-2012.
    Ren Fail. 2025;47:2575436.
    

    >> Share

    
    
32. FAN Z, Feng C, Li X, Zhang Z, et al
    Association between uric acid to high-density lipoprotein cholesterol ratio and chronic kidney disease in middle-aged and older adults: results from two nationally representative population-based study.
    Ren Fail. 2025;47:2575920.
    

    >> Share

    
    

    
    Transplantation

33. LIN L, Chen T, Yu S, Chen H, et al
    Normothermic Machine Perfusion Combined With Modified Small Interfering RNA Targeting Beta-2-microglobulin and Class II Major Histocompatibility Complex Transactivator Mitigates Acute Rejection of Renal Allograft.
    Transplantation. 2025 Oct 28. doi: 10.1097/TP.0000000000005529.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share